AAP Newsroom on MSN

Decision made on bid to stop Brisbane's Olympic stadium

The federal government has rejected an application to stop work on the 2032 Brisbane stadium site but appointed a mediator to ...
Next Mashup

Business Visa Australia: Expert Opinion on Securing Investment Opportunities

Learn how to secure a Business Visa Australia, explore investment pathways, achieve permanent residency with expert guidance ...
Morningstar

Duke Energy submits early site permit application for potential new nuclear development in North Carolina

CHARLOTTE, N.C., Dec. 30, 2025 /PRNewswire/ -- Duke Energy announced today its submission of an early site permit (ESP) application to the U.S. Nuclear Regulatory Commission (NRC) for a site near the ...
PR Newswire

Queensland Supreme Court Rules in Favour of BUMA Australia in Contract Mining Agreement Dispute

BRISBANE, Australia, Dec. 23, 2025 /PRNewswire/ -- BUMA Australia Pty Ltd ("BUMA Australia"), a wholly owned subsidiary of PT Bukit Makmur Mandiri Utama ("BUMA"), under Indonesian listed holding ...
PR Newswire

Startek Australia recognized as Employer of Choice and ABA100® winner for business excellence

MELBOURNE, Australia, Dec. 18, 2025 /PRNewswire/ -- Startek®, a digital-first global customer experience (CX) solutions provider, announced that in 2025, Startek Australia has been recognized as a ...
Morningstar

Brightstar Lottery Selected by Lotterywest to Deliver Industry-Leading Products Throughout Western Australia

LONDON, Dec. 18, 2025 /PRNewswire/ -- Brightstar Lottery PLC (NYSE: BRSL) ("Brightstar") announced today that its subsidiaries, Brightstar Global Solutions Corporation and Brightstar Lottery Australia ...
Seeking Alpha

F5 Expands Strategic Collaboration With NetApp to Enhance AI Application Performance and Safeguard Data With Post-Quantum Cryptography

SEATTLE--(BUSINESS WIRE)-- F5 (NASDAQ: FFIV) today announced an expanded collaboration with NetApp, the intelligent data infrastructure company, to drive high-performance AI data delivery and prepare ...
Seeking Alpha

AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

“ADDRI’s leadership in asbestos-related disease makes Australia a compelling setting for a TT-4 investigator-initiated trial,” said Peter Molloy, Chief Executive Officer, Cyncado Therapeutics. “We are ...